HSE refuses to fund ‘last chance’ trip

A young man is fighting for his life because the HSE has refused to fund a trip to New York for a “one last chance” treatment.

James Gill, 20, has a rare liver cancer — fibromellar hepatocellular carcinoma, also known as FLL-HCC — which affects only 200 new patients across the world every year.

The Memorial Sloan-Kettering Cancer Center in New York is one of the few facilities in the US with experience for caring for patients with James’ disease.